STAT+: ‘No magic bullet’: For drugmakers and the FDA, clinical trials on ultra-rare diseases pose thorny challenges
Walker Burger is beside himself with worry. The 33-year-old relies on an experimental medicine to…
Category: Pharma
STAT+: McDonald’s is criticized for leaving antibiotic reduction targets off its menu
Several advocacy groups have a beef with McDonald’s over its policy for using antibiotics in…
STAT+: Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs
In another setback for the pharmaceutical industry, a federal appeals court panel upheld a ruling…
STAT+: Pharmalittle: White House to launch effort for new generation of Covid shots; Indian court rejects bail pleas in Biocon bribery case
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation
Democrats have sent the legislative text of a sweeping proposal for drug price controls to…
STAT+: Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Roche CEO to step down next year; Gates Foundation withdraws financial support for malaria vaccine
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: Biogen agrees to pay $900 million to settle whistleblower case alleging kickbacks and sham speaking events
After a decade of legal squabbling, Biogen has agreed in principle to pay $900 million…
STAT+: Pharmalittle: Pharma and advocacy groups differ on vaccine equity; EC says Illumina-Grail deal breached merger rules
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharma and advocacy groups offer competing visions for achieving vaccine equity during pandemics
Amid criticism over its approach to Covid-19, the pharmaceutical industry has issued a new “declaration”…
STAT+: Pharmalittle: FDA user-fee reauthorization bill hits a snag; USPTO takes a tougher stand toward drugmakers
Rise and shine. Another busy day is on the way. Indeed, the official to-do list…
STAT+: Dozens of lawmakers urge HHS to fine drugmakers for curtailing discounts to a federal program
Dozens of lawmakers are demanding the Biden administration penalize drug companies that have curtailed discounts…
STAT+: Federal patent initiatives could cause ‘headwinds’ for drugmakers and their broad filings
For the second time this month, the U.S. Patent & Trademark Office has taken a…
STAT+: Contract research organization to transfer 4,000 beagles from facility cited for inhumane care
A contract research organization reached a final settlement with the U.S. government to transfer about…
STAT+: Pharmalittle: Biotech CEOs pull in some of health care’s biggest paydays; split emerges between groups providing abortion pills
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
A CEO pay bonanza, how much the rank and file are paid, and a wilderness therapy rabbit hole
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the…
Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged
Health care’s top executives sat comfortably atop their perch during the second year of the…
STAT+: Pharmalittle: Will the Supreme Court review controversial patent rulings? GSK prepares for its consumer health spinoff
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A Supreme Court review of a contentious patent issue would change the way pharma claims discoveries
In the coming weeks, the Supreme Court is expected to decide whether to review a…
STAT+: Pharmalittle: Teva asks U.S. Supreme Court to review skinny labeling; European Commission rebuked for Pfizer texts
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: Pharmalittle: Covid worsened antibiotic resistance; Teva and AbbVie unit settle opioid suit with San Francisco
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: ‘Eye-opening’: The pandemic accelerated antimicrobial resistance across the U.S.
Resistance to medicines for combating superbugs has considerably worsened during the pandemic, with deaths and…
STAT+: Pharmalittle: N.Y. AG claims Teva lied about its role in the opioid crisis; doctors question compounded versions of Novo weight loss drug
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: Perrigo seeks FDA approval to sell birth control over the counter; 1.1 billion Covid vaccines have been wasted
Good morning, everyone, and nice to see you again after we disappeared for a needed…
STAT+: Pharmalittle: California to make its own low-cost insulin; Theranos jury finds Balwani guilty on all counts
Good morning, one and all. Damian Garde here, filling in for Ed Silverman once again…
STAT+: Drug companies will have to start refunding Medicare for certain drugs that get thrown out
Starting next year, pharmaceutical companies will have to repay Medicare for any unused amount of drugs…
.jpg)
STAT+: Pharmalittle: Merck closes in on acquisition of Seagen; Intercept declares victory after re-analyzing NASH data
Good morning, everyone. Damian Garde here, filling in for Ed Silverman as the days of…
STAT+: Pharmalittle: Some scientists want more Vertex CRISPR data; Biogen Alzheimer’s drug to get priority review
Good morning. Elizabeth Cooney here, sitting in for Ed Silverman again, wishing him sunny skies…
STAT+: Pharmalittle: Market downturn chills VC climate; drug distributors prevail in W. Va. opioids case
Good morning. Elizabeth Cooney here again, pinch-hitting for Ed Silverman. Although he sometimes makes his…
STAT+: ‘A slippery slope’: Pfizer sells a contraceptive and donated to political groups that could come after the company
Generally speaking, a company would not want to contribute to a politician whose actions could…
STAT+: ‘A slippery slope’: Drugmakers that sell contraceptives donated to political groups that could come after them
Generally speaking, a company would not want to contribute to a politician whose actions could…
.jpg)
STAT+: Pharmalittle: Senate Dems vet a tweaked version of drug-pricing bill; biotechs double down on developing birth control products
And so, another working week will soon draw to a close. Not a moment too…
STAT+: The near-term outlook for pharma industry earnings just got a little worse
The near-term earnings outlook for the pharmaceutical industry was revised downward by a major credit…
STAT+: Pharmalittle: Pfizer and U.S. strike $3.2 billion deal for Covid vaccine; marketing of morning-after pills shifts to mail-order options
Good morning, everyone, and nice to see you again after we took an all-too-quick, day-long…
STAT+: Pharmalittle: FDA panel urges revamped Covid boosters; White House to widen access to monkeypox vaccine
Good morning. Elizabeth Cooney here, sitting in for Ed Silverman as he takes a day…
STAT+: 100 lawmakers ask HHS to use controversial federal laws to combat high drug prices
A group of 100 federal lawmakers is urging the Biden administration to use controversial provisions…
STAT+: Pharmalittle: Retailers ration contraceptive pills as demand spikes; Supreme Court rules doctors must knowingly misprescribe opioids to be convicted
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharma largely failed to follow human rights principles with its Covid-19 vaccines and drugs
More than two years after the Covid-19 pandemic emerged, a new scorecard finds that 19…
STAT+: Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: A ‘colossal financial fraud’: Gilead to get $33 million from a clinic for exploiting its HIV patient assistance program
After nearly two years of courtroom squabbling, Gilead Sciences reached a $33 million settlement with…
STAT+: Pharmalittle: Sarepta halts a Duchenne clinical trial over safety; Why the CVS Health whistleblower lawsuit comes at a pivotal moment
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A CVS whistleblower lawsuit comes at a pivotal moment for the FTC’s probe of pharma and PBMs
Three years ago, a former CVS Health executive told a U.S. Senate committee hearing that…
STAT+: Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Industry-funded studies on cost-effectiveness often favor pricier drugs, study finds
In response to rising prices for medicines, public and private payers increasingly rely on assessments…
STAT+: Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate
Amid concerns that patent reviewers disregard competitive effects on prescription drugs, a bipartisan group of…
STAT+: Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe
Top of the morning to you, and a fine one it is. The sun is…
STAT+: European researchers seek greater stake in drug development in bid to improve access
As the price of new medicines weighs on health payers in Europe, universities are seeking…
STAT+: Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy
Amid growing anger over the cost of medicines, a new analysis finds that Medicare could…